Aliconazole is an imidazole derivative of antifungal.

Aliconazole has previously been used in a phase III clinical trial to determine the efficacy in the topical treatment of cutaneous fungal infections. The proposed uses include including skin mucosal disease, superficial fungal infections, vaginal candidiasis, tinea versicolor, and skin [1].

63824-12-4

C18H13Cl3N2

363.67

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years